David van Duin, MD, PhD
Director, Immunocompromised Host Infectious Diseases Section
Associate Chief, Division of Infectious Diseases
Professor of Medicine, Division of Infectious Diseases
Areas of Interest
Infections in immunocompromised hosts; Gram-negative bacterial resistance
About
Dr. van Duin is the founding Director of the Immunocompromised Host Infectious Diseases Program – which provides consultative Infectious Diseases care to patients with transplants, malignancies, and burns. His primary research interests are antibacterial resistance in gram-negative bacilli and infections in vulnerable immunocompromised patient populations. He leads the consortium on resistance against carbapenems in Klebsiella and other Enterobacterales (CRACKLE) and the Multi-Drug Resistant Organism (MDRO) Network of the Antibacterial Resistance Leadership Group (ARLG). He is also supported by NIAID to evaluate community origins of carbapenem-resistant Enterobacterales in the US.
Memberships
- Infectious Diseases Society of America (IDSA)
- European Society for Clinical Microbiology and Infectious Diseases (ESCMID)
- American Society of Transplantation (AST)
- British Society for Antimicrobial Chemotherapy (BSAC)
In the news
Antimicrobial Resistant (AMR) research at the UNC Institute for Global Health and Infectious Diseases brings together collaborators from schools and departments across UNC. Following is an interview with David van Duin, MD, PhD, Brian Conlon, PhD, Luther Bartelt, MD, Tessa Andermann, MD, MPH, and Jonathan Juliano, MD, MSPH, DTM&H. Why is antimicrobial resistance an important issue? … Read more A nationwide analysis of a large, geographically diverse cohort of adults in the U.S. suggests there is an increased risk for hospital-acquired carbapenem-resistant enterobacterales (CRE) bloodstream infections among racial and ethnic minorities. Felicia Ruffin, PhD, is a researcher at Duke University School of Medicine in the research group of Vance Fowler, MD, MHS. For this … Read more Matthew Burns, age 33, was diagnosed with cystic fibrosis as a child, and for years experienced repeated lung infections. When the need for intravenous therapy and oxygen became more frequent, he received a lung transplant, a lifesaving opportunity for hope and healing. But a transplant surgery that might typically require a one-month hospital stay, turned … Read more From discovery to prevention to treatment, researchers at UNC-Chapel Hill are working to understand and mitigate the global rise of untreatable infections. Nearly every one of us has had an ailment that was treated with an antibiotic. Think about what would happen if that treatment didn’t work. More than 2.8 million antimicrobial-resistant — or treatment-resistant … Read more
Q&A: Investigators Discuss AMR Research at UNC’s Institute for Global Health and Infectious Diseases
Study Finds Increased Risk for Hospital-Acquired Bloodstream Infections Among Racial and Ethnic Minorities
An Opportunist Infection Following a Lung Transplant: Research Participant Shares His Story
Treatment-resistant infections, a “slow-moving catastrophe”
Education
-
Medical School
University of Amsterdam
-
Residency
Jacobi Hospital
-
Fellowship
Yale University
-
PhD
Yale University